PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
01-Aug-2024 As blood stock shortage crisis continues, less than half of Brits know their blood type, says expert London Medical Laboratory
01-Aug-2024 Novo Holdings Invests in UK-Listed Oxford Nanopore Technologies Novo Holdings
01-Aug-2024 INDEPENDENT PARSORTIX STUDY HIGHLIGHTS BENEFITS OF COMBINED DNA ANALYSIS IN MELANOMA ANGLE plc
01-Aug-2024 GenesisCare UK Strengthens Board with Appointment of Three Non-Executive Directors GenesisCare UK
31-Jul-2024 CellProthera begins long-term observational study to demonstrate safety and efficacy of ProtheraCytes® cell therapy in acute myocardial infarction CellProthera
30-Jul-2024 Five Questions about the Mpox Outbreak in the DRC Medecins sans frontieres - doctors without borders
30-Jul-2024 FOUR IN FIVE AGED 55 AND OVER ARE UNAWARE OF BLADDER CANCER AND ITS SYMPTOMS DESPITE BEING MOST AT RISK Merck Healthcare
30-Jul-2024 Panthera Biopartners opens York’s first dedicated clinical research site Panthera Biopartners
30-Jul-2024 Copley releases a new version of Inhalytix®, the go-to software for inhaler testing analysis Copley
30-Jul-2024 Clinion Wins The Clinical Trials Arena Excellence Award 2024 for Innovation Clinion
25-Jul-2024 ACG Packaging Materials wins prestigious Kepner-Tregoe (KT) Excellence Award ACG
24-Jul-2024 ImmunOs Therapeutics Expands Phase I Clinical Trial of IOS-1002 in Combination with KEYTRUDA® (pembrolizumab) for the Treatment of Solid Tumors ImmunOs Therapeutics
24-Jul-2024 SpyBiotech Announces the Completion of Enrollment in Phase I Trial of SPYVLP01 Targeting Human Cytomegalovirus (HCMV) SpyBiotech
23-Jul-2024 Vedanta Biosciences Expands Leadership Team and Appoints Head of Commercial PureTech Health
23-Jul-2024 ViroCell Biologics signs Master Services Agreement with prominent NCI-designated cancer center ViroCell
23-Jul-2024 ViiV Healthcare announces positive data demonstrating 2-drug regimen Dovato is as effective as 3-drug regimen Biktarvy for maintenance therapy of HIV-1 ViiV Healthcare
23-Jul-2024 ViiV Healthcare announces positive new data for Apretude use during pregnancy at AIDS 2024 ViiV Healthcare
23-Jul-2024 ViiV Healthcare premieres early data showing antiviral activity against integrase resistance from its investigational, third-generation integrase inhibitor AIDS 2024 ViiV Healthcare
23-Jul-2024 Xeltis appoints Shawn Gage as Vice President of US Clinical Affairs Xeltis
23-Jul-2024 ViroCell Biologics signs Master Services Agreement with prominent NCI-designated cancer center ViroCell